Inventor · disambiguated record
Shivakumar G. Kapsi
Also filed as: KAPSI SHIVAKUMAR · KAPSI SHIVAKUMAR G
6 granted patents·12 pending applications·40 citations·filing 2007–2019
85Inventor score
Top patents by PatentIndex Score
18 records- 0190US8052994B23′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)GLAXOSMITHKLINE LLC·Filed 2009·Granted Nov 8, 2011·9 cites·12 claims
- 0289US8052995B23'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene] hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)GLAXOSMITHKLINE LLC·Filed 2009·Granted Nov 8, 2011·8 cites·12 claims
- 0389US8052993B23′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)GLAXOSMITHKLINE LLC·Filed 2009·Granted Nov 8, 2011·7 cites·12 claims
- 0488US8071129B23′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)MULLER FRANCIS X·Filed 2009·Granted Dec 6, 2011·7 cites·12 claims
- 0588US8062665B23′-[(2Z)-[1-(3,4-dimethylphenyl)-1 ,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)MULLER FRANCIS X·Filed 2009·Granted Nov 22, 2011·7 cites·12 claims
- 0679US8828430B23′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)MULLER FRANCIS X·Filed 2011·Granted Sep 9, 2014·2 cites·12 claims
- 0772US2019209479A13'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)NOVARTIS AG·Filed 2019·Application pending·0 cites
- 0870US2018338926A13'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)NOVARTIS AG·Filed 2018·Application pending·0 cites
- 0968US2018117009A13'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)NOVARTIS AG·Filed 2017·Application pending·0 cites
- 1068US2014341991A13'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)GLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 1167US2017296512A13'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)NOVARTIS AG·Filed 2017·Application pending·0 cites
- 1265US2017112771A13'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)NOVARTIS AG·Filed 2016·Application pending·0 cites
- 1364US2010129352A1Novel pharmaceutical compositionMULLER FRANCIS X·Filed 2007·Application pending·0 cites
- 1463US2016199353A13'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)NOVARTIS AG·Filed 2016·Application pending·0 cites
- 1562US2016031822A13'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)NOVARTIS AG·Filed 2015·Application pending·0 cites
- 1662US2012149749A1Method of treating thrombocytopeniaARNING MICHAEL·Filed 2009·Application pending·0 cites
- 1757US2016143883A1Method of treating thrombocytopeniaKAPSI SHIVAKUMAR G·Filed 2015·Application pending·0 cites
- 1856US2014142155A1Method of treating thrombocytopeniaGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →